Abstract
The pharmacological specificities of the rectal formulation of acetaminophen led to a debate on its appropriateness for managing fever in children, but few data are available on the formulation’s current use and determinants of use. In a national cross-sectional study between 2007 and 2008, healthcare professionals were asked to include five consecutive patients with acute fever. Among the 6255 children (mean age 4.0 years ± 2.8 SD) who received acetaminophen given by parents or prescribed/recommended by healthcare professionals, determinants of suppository use were studied by multilevel models. A suppository was given by 27 % of parents and prescribed/recommended by 19 % of healthcare professionals, by 24 and 16 %, respectively, for children 2 to 5 years old, and by 13 and 8 %, respectively, for those 6 to 12 years old. Among children who received suppositories from parents and healthcare professionals, 83 and 84 %, respectively, did not vomit. Suppository use was independently associated with several patient- and healthcare professional-level characteristics: young age of children, presence of vomiting, or lack of diarrhea.
Conclusion: We report an enduring large use of suppositories in France for the symptomatic management of fever in children, including in non-vomiting and/or older children. The rational for such use should be questioned.
What is Known: • The pharmacological specificities of the rectal formulation of acetaminophen have led to a debate on its appropriateness for managing fever in children. Few data are available on the formulation’s current use and determinants of the use. |
What is New: • In a national cross-sectional study, we observed a large use of suppositories in France for symptomatic management of fever in children. Suppositories were frequently used for the youngest children but also for older and/or non-vomiting children. |
Similar content being viewed by others
Abbreviations
- aOR:
-
adjusted odds ratio
- OR:
-
odds ratio
References
Anderson BJ (1998) What we don’t know about paracetamol in children. Paediatr Anaesth 8:451–460
Anderson BJ, van Lingen RA, Hansen TG, Lin YC, Holford NH (2002) Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology 96:1336–1345
Anderson BJ, Woollard GA, Holford NH (2000) A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 50:125–134
Arana A, Morton NS, Hansen TG (2001) Treatment with paracetamol in infants. Acta Anaesthesiol Scand 45:20–29
Bertille N, Fournier-Charriere E, Pons G, Chalumeau M (2013) Managing fever in children: a national survey of parents’ knowledge and practices in France. PLoS One 8:e83469
Bertille N, Pons G, Khoshnood B, Fournier-Charriere E, Chalumeau M (2015) Symptomatic management of fever in children: a national survey of healthcare professionals’ practices in France. PLoS One 10:e0143230
Birmingham PK, Tobin MJ, Henthorn TK, Fisher DM, Berkelhamer MC, Smith FA, Fanta KB, Cote CJ (1997) Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology 87:244–252
Chiappini E, Parretti A, Becherucci P, Pierattelli M, Bonsignori F, Galli L, de Martino M (2012) Parental and medical knowledge and management of fever in Italian pre-school children. BMC Pediatr 12:97
Chiappini E, Principi N, Longhi R, Tovo PA, Becherucci P, Bonsignori F, Esposito S, Festini F, Galli L, Lucchesi B et al (2009) Management of fever in children: summary of the Italian Pediatric Society guidelines. Clin Ther 31:1826–1843
Chiappini E, Venturini E, Principi N, Longhi R, Tovo PA, Becherucci P, Bonsignori F, Esposito S, Festini F, Galli L et al (2012) Update of the 2009 Italian Pediatric Society Guidelines about management of fever in children. Clin Ther 34(1648-1653):e1643
Cullen S, Kenny D, Ward OC, Sabra K (1989) Paracetamol suppositories: a comparative study. Arch Dis Child 64:1504–1505
Goldstein LH, Berlin M, Berkovitch M, Kozer E (2008) Effectiveness of oral vs rectal acetaminophen: a meta-analysis. Arch Pediatr Adolesc Med 162:1042–1046
Hashiba K, Wo S, Yamamoto L (2015) Taste palatability of pediatric clindamycin and acetaminophen products. Paper presented at American Academy of Pediatrics National Conference & Exhibition Washington DC
Helgadottir HL, Wilson ME (2008) Parents’ knowledge and choice of paracetamol dosing forms in 3- to 6-year-old children. Scand J Caring Sci 22:93–97
Lava SA, Simonetti GD, Ferrarini A, Ramelli GP, Bianchetti MG (2013) Regional differences in symptomatic fever management among paediatricians in Switzerland: the results of a cross-sectional Web-based survey. Br J Clin Pharmacol 75:236–243
National Institute for Health and Clinical Excellence (2013) Fever in under 5s: assessment and initial management
Scolnik D, Kozer E, Jacobson S, Diamond S, Young NL (2002) Comparison of oral versus normal and high-dose rectal acetaminophen in the treatment of febrile children. Pediatrics 110:553–556
Smith CJ, Sammons HM, Fakis A, Conroy S (2013) A prospective study to assess the palatability of analgesic medicines in children. J Adv Nurs 69:655–663
Sullivan JE, Farrar HC (2011) Fever and antipyretic use in children. Pediatrics 127:580–587
Author’s contributions
NB performed the analyses, drafted the manuscript, and approved the final manuscript as submitted. GP conceptualized and designed the study, designed the data collection instruments, critically reviewed the manuscript, and approved the final manuscript as submitted. BK critically reviewed the statistical analyses and the manuscript, and approved the final manuscript as submitted. EFC conceptualized and designed the study, designed the data collection instruments, critically reviewed the manuscript, and approved the final manuscript as submitted. MC conceptualized and designed the study, designed the data collection instruments, supervised the data analyses, drafted the manuscript, and approved the final manuscript as submitted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial disclosure
NB is supported by an educational grant from Laboratoires Guigoz - Société Française de Pédiatrie - Groupe de Pédiatrie Générale - Groupe de Recherches Epidémiologiques en Pédiatrie and by Sorbonne Universités, UPMC Univ Paris 06 (educational grant of Ecole Doctorale 393). The work was also funded by Sanofi Aventis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interest
The work was funded by Sanofi Aventis, a pharmaceutical group that markets acetaminophen and ibuprofen. NB is supported by an educational grant from Laboratoires Guigoz - Société Française de Pédiatrie - Groupe de Pédiatrie Générale - Groupe de Recherches Epidémiologiques en Pédiatrie and by Sorbonne Universités, UPMC Univ Paris 06 (educational grant of Ecole Doctorale 393). EFC and GP received honoraria from Sanofi Aventis. MC belongs to the Assistance Publique-Hôpitaux de Paris, which has received research grants from Sanofi Aventis. We have no patents, products in development, or marketed products to declare. The other authors have no conflicts of interest to disclose.
Additional information
Communicated by Mario Bianchetti
Rights and permissions
About this article
Cite this article
Bertille, N., Fournier-Charrière, E., Pons, G. et al. Enduring large use of acetaminophen suppositories for fever management in children: a national survey of French parents and healthcare professionals’ practices. Eur J Pediatr 175, 987–992 (2016). https://doi.org/10.1007/s00431-016-2732-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-016-2732-8